Newer oral GLP-1 options like the Wegovy pill are more affordable currently around $149 per month but clinical trials show they deliver somewhat less weight loss than injectables, averaging around 1516% compared to 20% or more with injections. For patients who need significant weight loss to resolve health conditions, a lower-cost medication that produces fewer results may not be enough
Eating with the seasons is a simple yet powerful way to support your health, boost energy, and enjoy more flavorful foods
Salas-Whalen echoes the same idea
Besides, the GLP-1R/GGCR dual agonist, Cotadutide, was shown to relieve steatosis, inflammation and fibrosis in both Ob/Ob NASH mice model and C57BI/6J NASH mice model (131)
If significant side effects materialize, the high (and rising) sales of GLP-1 for weight loss treatment will likely attract the attention of plaintiff lawyers and litigation funders
Compounded versions arent approved by the FDA, meaning there isnt a process of verifying safety, effectiveness or quality of compounded medications before theyre marketed to consumers